CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
2409969-94-2 | m-PEG10-acid | | C22H44O12 | 500.58 | | |
241-55-4 | | indolo(3,2-b)carbazole | | | | |
241-62-3 | | 6h,13h-pyrazino(1,2-a:4,5-a')bisbenzimidazole | | | | |
2410-09-5 | | carbamic acid, acetylmethyl-, 4-(methylthio)-3,5-xylyl ester | | | | |
2410-93-7 | | glutamic acid, n-(p-(((2-amino-4-hydroxy-6-pteridyl)methyl)methylamino)benzoyl) | C20H21N7O6 | 455.42 | 144-150 °C | |
24100-16-1 | | 1-hexyl-2,4-dimethyl-cyclopentene | C13H24 | 180.33 | | |
24100-18-3 | | 2-Bromo-3-methoxypyridine | C6H6BrNO | 188.02 | 45-49 ℃(lit.) | |
2410032-62-9 | 2-(4-(二氟甲基)-2-氟苯基)-4,4,5,5-四甲基-1,3,2-二氧杂硼烷 | 2-(4-(Difluoromethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H16BF3O2 | 272.07 | | |
2410055-54-6 | 3-bromo-1,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-4-one | | C6H6N3OBr | 216.0351 | | |
2410075-48-6 | 7-Keto-abiraterone acetate | | C26H31NO3 | 405.53 | | |
2410085-45-7 | 2-(叔丁基(2-((二叔丁基膦基)甲基)苄基)膦基)吡啶 | 2-(tert-Butyl(2-((di-tert-butylphosphino)methyl)benzyl)phosphino)pyridine | C25H39NP2 | 415.53 | | |
24101-09-5 | 2-氯-5-(三氟甲基)嘧啶-4-胺 | 2-chloro-5-(trifluoromethyl)pyrimidin-4-amine | C5H3ClF3N3 | 197.55 | | 312.8±37.0 °C(Predicted) |
24101-91-5 | | diethyl 2-(4-chlorophenoxy)malonate | | | | |
24102-11-2 | | 2-n-propyl-4-pentynoic acid | | | | |
24102-89-4 | | 4-chloro-n-(2-(diethylamino)ethyl)-2-nitro-anilin | | | | |
2410215-84-6 | 4-Nitrophenyl ((5-(2,6-dioxopiperidin-3-yl)-4-oxo-5,6-dihydro-4H-thieno[3,4-c]pyrrol-1-yl)methyl)carbamate | | C19H16N4O7S | 444.425 | | |
2410215-91-5 | 4-Nitrophenyl ((5-(2,6-dioxopiperidin-3-yl)-6-oxo-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl)methyl)carbamate | | C19H16N4O7S | 444.425 | | |
2410236-85-8 | BOC-NH-PEG2-propene | | C12H23NO4 | 245.32 | | |
2410279-93-3 | Taurocholic Acid-d4 (sodium salt) | | C26H44NNaO7S | 541.71 | | |
2410284-89-6 | 2,2'-(哌嗪-1,4-二基)双(N-(4-氨基苯基)-N-甲基乙酰胺) | 2,2'-(Piperazine-1,4-diyl)bis(N-(4-aminophenyl)-N-methylacetamide) | C22H30N6O2 | 410.51 | | |
2410284-90-9 | Nintedanib Impurity 50 | | C56H52N8O8 | 965.08 | | |
24103-75-1 | 4-甲氧基-2-甲基吡啶 | 4-methoxy-2-methylpyridine | C7H9NO | 123.15 | | 184.4°C |
2410309-56-5 | ethyl 8-chloro-1,7-naphthyridine-3-carboxylate | | C11H9N2O2Cl | 236.654 | | |
2410309-58-7 | 8-((叔丁氧羰基)氨基)-1,7-萘啶-3-羧酸乙酯 | Ethyl 8-((tert-butoxycarbonyl)amino)-1,7-naphthyridine-3-carboxylate | C16H19N3O4 | 317.34 | | 423.5±40.0 °C(Predicted) |
2410309-62-3 | ethyl 8-amino-5-bromo-1,7-naphthyridine-3-carboxylate | | C11H10N3O2Br | 296.1196 | | |
2410309-70-3 | 2-(4-(4-溴苯基)-1H-吡唑-1-基)-N,N-二甲基乙酰胺 | 2-(4-(4-Bromophenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide | C13H14BrN3O | 308.17 | | |
2410401-58-8 | N-(二苯并[b,d]呋喃-3-基)-9-苯基-9H-咔唑-2-胺 | N-(Dibenzo[b,d]furan-3-yl)-9-phenyl-9H-carbazol-2-amine | C30H20N2O | 424.49 | | |
2410423-38-8 | 3-(3-(5-(4-Methylpiperazin-1-yl)pentyloxy)phenyl)thiazolidine-2,4-dione | | C19H27N3O3S | 377.508 | | |
2410440-12-7 | 3-(4,4,5,5-四甲基-1,3,2-二氧杂环戊烷-2-基)双环[1.1.1]戊烷-1-羧酸甲酯 | Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pentane-1-carboxylate | C13H21BO4 | 252.11 | | 272.1±40.0 °C at 760 mmHg |
2410440-14-9 | 2-(3-(三氟甲基)双环[1.1.1]戊基-1-基)-硼酸频哪醇酯 | 4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)-1,3,2-dioxaborolane | C12H18BF3O2 | 262.08 | | |
2410445-32-6 | (4S,4's)-2,2'-异丙亚基双(4-(3,5-二(萘-2-基)苯基)-2-噁唑啉) | (4S,4's)-2,2'-(propane-2,2-diyl)bis(4-(3,5-di(naphthalen-2-yl)phenyl)-4,5-dihydrooxazole) | | | | |
2410512-38-6 | JQKD82 | | C27H40N4O5 | 500.64 | | |
2410538-67-7 | α-Glucosidase-IN-4 | | C19H14O4 | 306.31 | | 510.4±49.0 °C(Predicted) |
2410550-75-1 | Methyl 1-(3,4-dichlorophenyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | | C15H10Cl2N2O2 | 321.163 | | |
2410550-76-2 | 1-(3,4-Dichlorophenyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid | | C14H8Cl2N2O2 | 307.136 | | |
2410557-00-3 | iRucaparib-AP6 | | C46H55FN6O11 | 886.96 | | |
2410559-72-5 | 双环[1.1.1]戊基-1-基三氟硼酸钾 | Potassium bicyclo[1.1.1]pentan-1-yltrifluoroborate | C5H7BF3K | 174.01 | | |
2410559-74-7 | 三氟[3-(甲氧基羰基)双环[1.1.1]戊烷-1-基]硼酸钾 | Potassium Trifluoro[3-(methoxycarbonyl)bicyclo[1.1.1]pentan-1-yl]borate | C7H9BF3KO2 | 232.05 | 265 °C | |
2410598-01-3 | Boc-NH-PEG10-CH2CH2COOH | | C28H55NO14 | 629.73 | | |
24106-05-6 | | Acetamide,N-(4-bromo-2-methylphenyl)- | C9H10BrNO | 228.09 | 160-163℃ | |
24106-86-3 | | 2-(2-fluorobenzyl)acetoacetic acid ethyl ester | C13H15FO3 | 238.25 | | 309.7 °C at 760 mmHg |
2410600-95-0 | 1-(2,2-Bis(4-(trifluoromethyl)phenyl)vinyl)piperidin-2-one | | C21H17F6NO | 413.362 | | |
2410612-08-5 | FGFR1 inhibitor-2 | | C25H22F5N3O3 | 507.45 | | |
2410639-38-0 | (6S,6aS)-6-triphenylsilyloxy-4,5,6,6a-tetrahydro-1H-pentalen-2-one | | C26H24O2Si | 396.55 | | 487.4±34.0 °C(Predicted) |
2410639-39-1 | (2R,6S,6aS)-6-triphenylsilyloxy-1,2,4,5,6,6a-hexahydropentalen-2-ol | | C26H26O2Si | 398.57 | | |
2410649-54-4 | 2,2'-(哌嗪-1,4-二基)双(N-甲基-N-(4-硝基苯基)乙酰胺)(尼达尼布杂质) | 2,2'-(Piperazine-1,4-diyl)bis(N-methyl-N-(4-nitrophenyl)acetamide)(NintedanibImpurity) | C22H26N6O6 | 470.48 | | |
24107-34-4 | | 2,3-dihydro-2,2,4-trimethyl-1h-1,5-benzodiazepine | | | | |
24107-64-0 | | (2,4-dimethyl-1,3-pentadienyl)benzene | C13H16 | 172.27 | | |
24107-65-1 | | 1-(2,4-dimethyl-1,3-pentadienyl)-4-methylbenzene | C14H18 | 186.29 | | |
24107-66-2 | | benzene,1-(2,4-dimethyl-1,3-pentadienyl)-3-methyl- | C14H18 | 186.29 | | |